Transforming growth factor beta (TGF-β) is considered one of the most potent inducers of EMT, both in vitro and in vivo, exerting a critical tumor-promoting function in advanced stages of NSCLC [13,14]. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.